Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valacyclovir PK in Neonates With HSV
NCT04448392Phase 1Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- Jul 2021
- Primary completion
- Jul 2024
- Modality
- Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 1, open-label trial of valaciclovir in herpes simplex virus infection, sponsored by University of Alabama at Birmingham. Primary endpoints: Area Under the Curve Following Administration of Oral Valacyclovir Suspension at Day 7 and Creatinine Clearance Following Administration of Oral Valacyclovir Suspension at Day 7. Started Jul 2021; status: completed.
02
Drugs
valaciclovir
03
Conditions
herpes simplex virus infection
Beyond the preview
Go deeper on NCT04448392.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04448392.